↓ Skip to main content

Dove Medical Press

Article Metrics

Technology that achieves the Triple Aim: an economic analysis of the BrainPathTM approach  in neurosurgery

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, August 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#12 of 380)
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
5 news outlets
twitter
1 tweeter
video
1 video uploader

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
21 Mendeley
Title
Technology that achieves the Triple Aim: an economic analysis of the BrainPath<sup>TM</sup>&nbsp;approach&nbsp;&nbsp;in neurosurgery
Published in
ClinicoEconomics and Outcomes Research: CEOR, August 2017
DOI 10.2147/ceor.s133623
Pubmed ID
Authors

Sidney Norton, Evan Dickerson, Charles Kulwin, Mitesh Shah

Abstract

The Triple Aim is defined as: improving the patient experience of care, improving the health of populations, and reducing the per capita cost of health care. The purpose of this analysis was to evaluate the economic value of a new neurosurgical technique, the BrainPath™ approach, for use in patients with subcortical tumors and intracerebral hemorrhage (ICH). Inpatient length of stay (LOS) data were collected for ICH and brain tumor surgical patient cases between August 2013 and November 2015. Patient cases were separated into two groups; BrainPath approach (n = 28) and conventional techniques, such as craniotomy, (n = 208). The average intensive care unit (ICU) LOS was calculated for each group by diagnosis-related group and compared between groups. The new surgical technology resulted in surgical intervention in 14 ICH cases which otherwise would have been medically managed due to the hemorrhage location or size of the ICH. A reduction in ICU LOS was seen in this group. Based on the variable direct cost per day in the neuro critical care unit at this academic medical center, 14 patient cases incurred ~ US$210,000 less in direct ICU costs. Surgical resection was possible in two tumor patient cases which would have been biopsied, rather than surgically resected, also due to location of the abnormalities. A total net value of > US$329,000 is attributable to the analyzed approach over a 28-month period. This analysis shows positive economic value for the new technology group when ICU LOS and reimbursement are considered against equipment costs, thus achieving Triple Aim objectives.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 19%
Other 3 14%
Student > Doctoral Student 3 14%
Student > Bachelor 3 14%
Student > Postgraduate 2 10%
Other 6 29%
Readers by discipline Count As %
Medicine and Dentistry 10 48%
Neuroscience 3 14%
Agricultural and Biological Sciences 2 10%
Nursing and Health Professions 2 10%
Economics, Econometrics and Finance 1 5%
Other 2 10%
Unknown 1 5%

Attention Score in Context

This research output has an Altmetric Attention Score of 41. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 October 2017.
All research outputs
#511,053
of 15,246,727 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#12
of 380 outputs
Outputs of similar age
#16,890
of 271,909 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#2
of 13 outputs
Altmetric has tracked 15,246,727 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 380 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,909 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.